{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:55:28Z","timestamp":1792032928544,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202312380"],"award-info":[{"award-number":["tsqn202312380"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82472667"],"award-info":[{"award-number":["No. 82472667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573927"],"award-info":[{"award-number":["82573927"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["NO. H2020206301"],"award-info":[{"award-number":["NO. H2020206301"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["NO. H2023206222"],"award-info":[{"award-number":["NO. H2023206222"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cyclin-dependent kinase 13 (CDK13) has emerged as a critical regulator of oncogenic metabolism, but its role in rewiring lipid metabolism in clear cell renal cell carcinoma (ccRCC) remains undefined. Here we identify CDK13 as a master orchestrator of lipid dysregulation in ccRCC, demonstrating that it drives de novo lipogenesis through a phosphorylation-dependent RNA\n                    <jats:italic>N<\/jats:italic>\n                    <jats:sup>6<\/jats:sup>\n                    -methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) modification axis. Clinically, CDK13 overexpression correlates with advanced tumor stage, poor prognosis and aberrant lipid accumulation in patient-derived ccRCC tissues. Mechanistically, CDK13 directly phosphorylates the methyltransferase-like protein 16 (METTL16) at Ser329, augmenting its catalytic activity to install m\n                    <jats:sup>6<\/jats:sup>\n                    A modifications on ATP-citrate synthase (ACLY) messenger RNA. These m\n                    <jats:sup>6<\/jats:sup>\n                    A marks are selectively recognized by the YTHDC2 reader protein, leading to mRNA stabilization and increased acetyl-CoA production, which fuels lipogenesis and sustains ccRCC aggressiveness. Genetic or pharmacological disruption of the CDK13\u2013METTL16\u2013ACLY axis synergistically suppresses lipid deposition, tumor growth and metastasis in vitro and in vivo. Notably, targeting CDK13 with the small-molecule inhibitor 1NM-PP1 potentiates METTL16 depletion-mediated anticancer effects. Our findings establish a kinase-RNA modifier axis that links CDK13 to epitranscriptomic control of lipid metabolism, positioning the CDK13\u2013METTL16\u2013ACLY pathway as a promising target for precision therapies against ccRCC.\n                  <\/jats:p>","DOI":"10.1038\/s12276-025-01634-7","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:49:36Z","timestamp":1770889776000},"page":"472-486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["CDK13 drives clear cell renal carcinoma through METTL16-mediated m6A modification of ACLY mRNA"],"prefix":"10.1038","volume":"58","author":[{"given":"Jinsuo","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changbao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanxi","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongye","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7191-2910","authenticated-orcid":false,"given":"Zhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"1634_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41585-022-00654-6","volume":"20","author":"SK Tan","year":"2023","unstructured":"Tan, S. K., Hougen, H. Y., Merchan, J. R., Gonzalgo, M. L. & Welford, S. M. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets. Nat. Rev. Urol. 20, 48\u201360 (2023).","journal-title":"Nat. Rev. Urol."},{"key":"1634_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrneph.2017.59","volume":"13","author":"HI Wettersten","year":"2017","unstructured":"Wettersten, H. I., Aboud, O. A., Lara, P. N. & Weiss, R. H. Metabolic reprogramming in clear cell renal cell carcinoma. Nat. Rev. Nephrol. 13, 410\u2013419 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"1634_CR3","doi-asserted-by":"publisher","first-page":"R207","DOI":"10.1530\/ERC-20-0457","volume":"28","author":"F Turco","year":"2021","unstructured":"Turco, F. et al. Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC. Endocr. Relat. Cancer 28, R207\u2013R216 (2021).","journal-title":"Endocr. Relat. Cancer"},{"key":"1634_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros, N. & Poulogiannis, G. Reprogramming of fatty acid metabolism in cancer. Br. J. Cancer 122, 4\u201322 (2020).","journal-title":"Br. J. Cancer"},{"key":"1634_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.820154","volume":"12","author":"M He","year":"2021","unstructured":"He, M. et al. A new prognostic risk score: based on the analysis of autophagy-related genes and renal cell carcinoma. Front. Genet. 12, 820154 (2021).","journal-title":"Front. Genet."},{"key":"1634_CR6","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1158\/1535-7163.MCT-17-1299","volume":"17","author":"P Makhov","year":"2018","unstructured":"Makhov, P. et al. Resistance to systemic therapies in clear cell renal cell carcinoma: mechanisms and management strategies. Mol. Cancer Ther. 17, 1355\u20131364 (2018).","journal-title":"Mol. Cancer Ther."},{"key":"1634_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/hep.31249","volume":"73","author":"L Gu","year":"2021","unstructured":"Gu, L. et al. The IKK\u03b2-USP30-ACLY axis controls lipogenesis and tumorigenesis. Hepatology 73, 160\u2013174 (2021).","journal-title":"Hepatology"},{"key":"1634_CR8","first-page":"188559","volume":"1876","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K. & Pal, S. Metabolic reprogramming in renal cancer: Events of a metabolic disease. Biochimica et Biophysica Acta 1876, 188559 (2021).","journal-title":"Biochimica et Biophysica Acta"},{"key":"1634_CR9","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.1038\/sj.onc.1208773","volume":"24","author":"DE Bauer","year":"2005","unstructured":"Bauer, D. E., Hatzivassiliou, G., Zhao, F., Andreadis, C. & Thompson, C. B. ATP citrate lyase is an important component of cell growth and transformation. Oncogene 24, 6314\u20136322 (2005).","journal-title":"Oncogene"},{"key":"1634_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0065-2571(72)90014-3","volume":"10","author":"DM Gibson","year":"1972","unstructured":"Gibson, D. M., Lyons, R. T., Scott, D. F. & Muto, Y. Synthesis and degradation of the lipogenic enzymes of rat liver. Adv. Enzyme Regul. 10, 187\u2013204 (1972).","journal-title":"Adv. Enzyme Regul."},{"key":"1634_CR11","doi-asserted-by":"publisher","first-page":"8117","DOI":"10.1158\/0008-5472.CAN-09-3871","volume":"70","author":"E Rysman","year":"2010","unstructured":"Rysman, E. et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res. 70, 8117\u20138126 (2010).","journal-title":"Cancer Res."},{"key":"1634_CR12","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/nm.4181","volume":"22","author":"RU Svensson","year":"2016","unstructured":"Svensson, R. U. et al. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models. Nat. Med. 22, 1108\u20131119 (2016).","journal-title":"Nat. Med."},{"key":"1634_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual, G. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541, 41\u201345 (2017).","journal-title":"Nature"},{"key":"1634_CR14","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/1541-7786.MCR-22-0781","volume":"21","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. lncRNA-encoded micropeptide ACLY-BP drives lipid deposition and cell proliferation in clear cell renal cell carcinoma via maintenance of ACLY acetylation. Mol. Cancer Res. 21, 1064\u20131078 (2023).","journal-title":"Mol. Cancer Res."},{"key":"1634_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara, S., Ries, R. J. & Jaffrey, S. R. Reading, writing and erasing mRNA methylation. Nat. Rev. Mol. Cell Biol. 20, 608\u2013624 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1634_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres, M. & Barbacid, M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Can. 9, 153\u2013166 (2009).","journal-title":"Nat. Rev. Can."},{"key":"1634_CR17","doi-asserted-by":"publisher","first-page":"940","DOI":"10.15252\/msb.20167321","volume":"13","author":"M Tarrado-Castellarnau","year":"2017","unstructured":"Tarrado-Castellarnau, M. et al. De novo MYC addiction as an adaptive response of cancer cells to CDK4\/6 inhibition. Mol. Syst. Biol. 13, 940 (2017).","journal-title":"Mol. Syst. Biol."},{"key":"1634_CR18","doi-asserted-by":"publisher","first-page":"e0149184","DOI":"10.1371\/journal.pone.0149184","volume":"11","author":"Y Even","year":"2016","unstructured":"Even, Y., Escande, M.-L., Fayet, C. & Genevi\u00e8re, A.-M. CDK13, a kinase involved in pre-mRNA splicing, is a component of the perinucleolar compartment. PloS ONE 11, e0149184 (2016).","journal-title":"PloS ONE"},{"key":"1634_CR19","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1038\/s41418-023-01223-z","volume":"30","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA. Cell Death Differ. 30, 2462\u20132476 (2023).","journal-title":"Cell Death Differ."},{"key":"1634_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13046-020-01814-5","volume":"40","author":"J-C Qi","year":"2021","unstructured":"Qi, J.-C. et al. CDK13 upregulation-induced formation of the positive feedback loop among circCDK13, miR-212-5p\/miR-449a and E2F5 contributes to prostate carcinogenesis. J. Exp. Clin. Cancer Res. 40, 2 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1634_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz5041","volume":"6","author":"Z Fan","year":"2020","unstructured":"Fan, Z. et al. CDK13 cooperates with CDK12 to control global RNA polymerase II processivity. Sci. Adv. 6, eaaz5041 (2020).","journal-title":"Sci. Adv."},{"key":"1634_CR22","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101645R","volume":"36","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Estrogen receptor beta increases clear cell renal cell carcinoma stem cell phenotype via altering the circPHACTR4\/miR-34b-5p\/c-Myc signaling. FASEB J. 36, e22163 (2022).","journal-title":"FASEB J."},{"key":"1634_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer. Nat. Commun. 14, 6523 (2023).","journal-title":"Nat. Commun."},{"key":"1634_CR24","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1038\/s41388-018-0602-8","volume":"38","author":"Z Yang","year":"2019","unstructured":"Yang, Z. et al. Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway. Oncogene 38, 2516\u20132532 (2019).","journal-title":"Oncogene"},{"key":"1634_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12964-022-00831-5","volume":"20","author":"Z Liu","year":"2022","unstructured":"Liu, Z., Sun, T., Piao, C., Zhang, Z. & Kong, C. METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma. Cell Commun. Signal. 20, 36 (2022).","journal-title":"Cell Commun. Signal."},{"key":"1634_CR26","doi-asserted-by":"publisher","first-page":"e70232","DOI":"10.1002\/ctm2.70232","volume":"15","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. METTL14-mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination. Clin. Transl. Med. 15, e70232 (2025).","journal-title":"Clin. Transl. Med."},{"key":"1634_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.omtn.2021.12.024","volume":"27","author":"D Shen","year":"2022","unstructured":"Shen, D. et al. METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination. Mol. Ther. Nucleic Acids 27, 547\u2013561 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1634_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41416-022-01757-y","volume":"127","author":"L Zhang","year":"2022","unstructured":"Zhang, L., Luo, X. & Qiao, S. METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma. Br. J. Cancer 127, 30\u201342 (2022).","journal-title":"Br. J. Cancer"},{"key":"1634_CR29","doi-asserted-by":"crossref","unstructured":"Shi, Y. et al. The RNA N6-methyladenosine methyltransferase METTL3 promotes the progression of kidney cancer via N6-methyladenosine-dependent translational enhancement of ABCD1. Front. Cell Dev. Biol. 9, (2021).","DOI":"10.3389\/fcell.2021.737498"},{"key":"1634_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12967-022-03496-3","volume":"20","author":"D Zhu","year":"2022","unstructured":"Zhu, D. et al. The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma. J. Transl. Med. 20, 298 (2022).","journal-title":"J. Transl. Med."},{"key":"1634_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13045-023-01477-7","volume":"16","author":"Y-N Qi","year":"2023","unstructured":"Qi, Y.-N., Liu, Z., Hong, L.-L., Li, P. & Ling, Z.-Q. Methyltransferase-like proteins in cancer biology and potential therapeutic targeting. J. Hematol. Oncol. 16, 89 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"1634_CR32","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi, H., Wei, J. & He, C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol. Cell 74, 640\u2013650 (2019).","journal-title":"Mol. Cell"},{"key":"1634_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10555-021-09996-w","volume":"41","author":"G Heravi","year":"2022","unstructured":"Heravi, G., Yazdanpanah, O., Podgorski, I., Matherly, L. H. & Liu, W. Lipid metabolism reprogramming in renal cell carcinoma. Cancer Metastasis Rev. 41, 17\u201331 (2022).","journal-title":"Cancer Metastasis Rev."},{"key":"1634_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","volume":"10","author":"I Pellarin","year":"2025","unstructured":"Pellarin, I. et al. Cyclin-dependent protein kinases and cell cycle regulation in biology and disease. Signal Transduct. Target. Ther. 10, 11 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1634_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn7625","volume":"380","author":"ML Insco","year":"2023","unstructured":"Insco, M. L. et al. Oncogenic CDK13 mutations impede nuclear RNA surveillance. Science 380, eabn7625 (2023).","journal-title":"Science"},{"key":"1634_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang, P., Doxtader, K. A. & Nam, Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell 63, 306\u2013317 (2016).","journal-title":"Mol Cell"},{"key":"1634_CR37","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1007\/s11010-025-05346-4","volume":"480","author":"B Fan","year":"2025","unstructured":"Fan, B. et al. METTL16 promotes progression of clear cell renal cell carcinoma via up-regulating N6-methyladenosine modification of KLK4 mRNA. Mol. Cell Biochem. 480, 5741\u20135751 (2025).","journal-title":"Mol. Cell Biochem."},{"key":"1634_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01575-z","volume":"21","author":"A Du","year":"2022","unstructured":"Du, A. et al. m6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Mol. Cancer 21, 109 (2022).","journal-title":"Mol. Cancer"},{"key":"1634_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111952","volume":"134","author":"T Xie","year":"2025","unstructured":"Xie, T. et al. Unraveling m6A RNA methylation: from epitranscriptomics to therapeutic frontiers in renal cell carcinoma. Cell Signal. 134, 111952 (2025).","journal-title":"Cell Signal."},{"key":"1634_CR40","doi-asserted-by":"publisher","first-page":"e03323","DOI":"10.1002\/advs.202503323","volume":"12","author":"J Wen","year":"2025","unstructured":"Wen, J. et al. Deacetylation of ACLY mediates RNA M6A-modification of NOXA and promotes chemoresistance of colorectal cancer. Adv. Sci. 12, e03323 (2025).","journal-title":"Adv. Sci."},{"key":"1634_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/onc.2017.338","volume":"37","author":"D Tarade","year":"2018","unstructured":"Tarade, D. & Ohh, M. The HIF and other quandaries in VHL disease. Oncogene 37, 139\u2013147 (2018).","journal-title":"Oncogene"},{"key":"1634_CR42","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/s42003-025-08877-0","volume":"8","author":"K Li","year":"2025","unstructured":"Li, K. et al. CPT2 inhibition enhances selective autophagy and proliferation in colorectal cancer via GPAT4-dependent glycerophospholipid biosynthesis. Commun. Biol. 8, 1480 (2025).","journal-title":"Commun. Biol."},{"key":"1634_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217698","volume":"624","author":"Z Shi","year":"2025","unstructured":"Shi, Z. et al. RNA methyltransferase METTL16: from molecular mechanisms to therapeutic prospects in cancers. Cancer Lett. 624, 217698 (2025).","journal-title":"Cancer Lett."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01634-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01634-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01634-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:04:01Z","timestamp":1773839041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01634-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1634"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01634-7","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}